These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 11418763)

  • 1. Structure of a new polymorphic monoclinic form of human transthyretin at 3 A resolution reveals a mixed complex between unliganded and T4-bound tetramers of TTR.
    Wojtczak A; Neumann P; Cody V
    Acta Crystallogr D Biol Crystallogr; 2001 Jul; 57(Pt 7):957-67. PubMed ID: 11418763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ligand binding at the transthyretin dimer-dimer interface: structure of the transthyretin-T4Ac complex at 2.2 Angstrom resolution.
    Neumann P; Cody V; Wojtczak A
    Acta Crystallogr D Biol Crystallogr; 2005 Oct; 61(Pt 10):1313-9. PubMed ID: 16204882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure of rat transthyretin (rTTR) complex with thyroxine at 2.5 A resolution: first non-biased insight into thyroxine binding reveals different hormone orientation in two binding sites.
    Wojtczak A; Cody V; Luft JR; Pangborn W
    Acta Crystallogr D Biol Crystallogr; 2001 Aug; 57(Pt 8):1061-70. PubMed ID: 11468389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structures of human transthyretin complexed with thyroxine at 2.0 A resolution and 3',5'-dinitro-N-acetyl-L-thyronine at 2.2 A resolution.
    Wojtczak A; Cody V; Luft JR; Pangborn W
    Acta Crystallogr D Biol Crystallogr; 1996 Jul; 52(Pt 4):758-65. PubMed ID: 15299640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structure of rat transthyretin at 2.5 A resolution: first report on a unique tetrameric structure.
    Wojtczak A
    Acta Biochim Pol; 1997; 44(3):505-17. PubMed ID: 9511961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis of negative cooperativity in transthyretin.
    Neumann P; Cody V; Wojtczak A
    Acta Biochim Pol; 2001; 48(4):867-75. PubMed ID: 11995997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystallographic study of novel transthyretin ligands exhibiting negative-cooperativity between two thyroxine binding sites.
    Tomar D; Khan T; Singh RR; Mishra S; Gupta S; Surolia A; Salunke DM
    PLoS One; 2012; 7(9):e43522. PubMed ID: 22973437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural evidence for asymmetric ligand binding to transthyretin.
    Cianci M; Folli C; Zonta F; Florio P; Berni R; Zanotti G
    Acta Crystallogr D Biol Crystallogr; 2015 Aug; 71(Pt 8):1582-92. PubMed ID: 26249340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High resolution crystal structures of piscine transthyretin reveal different binding modes for triiodothyronine and thyroxine.
    Eneqvist T; Lundberg E; Karlsson A; Huang S; Santos CR; Power DM; Sauer-Eriksson AE
    J Biol Chem; 2004 Jun; 279(25):26411-6. PubMed ID: 15082720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structure determination at 2.3-A resolution of human transthyretin-3',5'-dibromo-2',4,4',6-tetrahydroxyaurone complex.
    Ciszak E; Cody V; Luft JR
    Proc Natl Acad Sci U S A; 1992 Jul; 89(14):6644-8. PubMed ID: 1631168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of molecular recognition. Structural aspects of 3,3'-diiodo-L-thyronine binding to human serum transthyretin.
    Wojtczak A; Luft J; Cody V
    J Biol Chem; 1992 Jan; 267(1):353-7. PubMed ID: 1730601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural and dynamics evidence for scaffold asymmetric flexibility of the human transthyretin tetramer.
    Zanotti G; Vallese F; Ferrari A; Menozzi I; Saldaño TE; Berto P; Fernandez-Alberti S; Berni R
    PLoS One; 2017; 12(12):e0187716. PubMed ID: 29240759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transthyretin suppresses the toxicity of oligomers formed by misfolded proteins in vitro.
    Cascella R; Conti S; Mannini B; Li X; Buxbaum JN; Tiribilli B; Chiti F; Cecchi C
    Biochim Biophys Acta; 2013 Dec; 1832(12):2302-14. PubMed ID: 24075940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetic stabilization of an oligomeric protein by a single ligand binding event.
    Wiseman RL; Johnson SM; Kelker MS; Foss T; Wilson IA; Kelly JW
    J Am Chem Soc; 2005 Apr; 127(15):5540-51. PubMed ID: 15826192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new crystal form of human transthyretin obtained with a curcumin derived ligand.
    Polsinelli I; Nencetti S; Shepard W; Ciccone L; Orlandini E; Stura EA
    J Struct Biol; 2016 Apr; 194(1):8-17. PubMed ID: 26796656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of transthyretin in the transport of thyroxine from the blood to the choroid plexus, the cerebrospinal fluid, and the brain.
    Chanoine JP; Alex S; Fang SL; Stone S; Leonard JL; Körhle J; Braverman LE
    Endocrinology; 1992 Feb; 130(2):933-8. PubMed ID: 1733735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conserved water mediated H-bonding dynamics of Ser117 and Thr119 residues in human transthyretin-thyroxin complexation: inhibitor modeling study through docking and molecular dynamics simulation.
    Banerjee A; Bairagya HR; Mukhopadhyay BP; Nandi TK; Mishra DK
    J Mol Graph Model; 2013 Jul; 44():70-80. PubMed ID: 23732306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure of human transthyretin complexed with bromophenols: a new mode of binding.
    Ghosh M; Meerts IA; Cook A; Bergman A; Brouwer A; Johnson LN
    Acta Crystallogr D Biol Crystallogr; 2000 Sep; 56(Pt 9):1085-95. PubMed ID: 10957627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of molecular recognition: crystal structure analysis of human and rat transthyretin inhibitor complexes.
    Cody V
    Clin Chem Lab Med; 2002 Dec; 40(12):1237-43. PubMed ID: 12553424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the glutamic acid 54 residue in transthyretin stability and thyroxine binding.
    Miyata M; Sato T; Mizuguchi M; Nakamura T; Ikemizu S; Nabeshima Y; Susuki S; Suwa Y; Morioka H; Ando Y; Suico MA; Shuto T; Koga T; Yamagata Y; Kai H
    Biochemistry; 2010 Jan; 49(1):114-23. PubMed ID: 19950966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.